Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.MGI announces positive results from Gliadel combination study
The study was led by Ronald Warnick, chairman of the Mayfield Clinic and professor of neurosurgery at the University of Cincinnati. The study is claimed to be the
The study was led by Ronald Warnick, chairman of the Mayfield Clinic and professor of neurosurgery at the University of Cincinnati. The study is claimed to be the
In addition, in connection with the transaction, Silipos, a wholly owned subsidiary of Langer, formed a strategic partnership with Sole Solutions and Langer UK through which Sole Solutions
Stephen Beatty, president and CEO of Helix BioMedix, said: “This agreement is significant for Helix BioMedix as it addresses several critical components that are important to the company
Accentia intends to use the proceeds as working capital, including supporting drug development, regulatory strategies and marketing plans. The financing provides investors with the right to convert their
The test is intended for use by laboratories to screen individual donations of blood and plasma for antibodies to human T-lymphotropic virus type I and/or human T-lymphotropic virus
Mr Osborne had served as the company’s interim CFO since October 1, 2007. Prior to VNUS, he held various finance leadership and management roles at Sanmina-SCI, Mercury Interactive/HP,
MRX-4 was nasally administered as a single dose once a week for four consecutive weeks. The first administration was given without a nasal allergen challenge (NAC) while the
Welchol (colesevelam HCl) is now claimed to be the first and only medication approved to reduce both glucose levels (colesevelam HCl) and low density lipoprotein cholesterol levels. Joseph
Exelixis previously said that XL784 failed to meet its primary endpoint in a Phase II trial. Although the data in one subgroup were encouraging, Exelixis believes that the
Humira has been approved for the treatment of adult patients with moderate to severe chronic plaque psoriasis who are candidates for systemic therapy or phototherapy, and when other